Efficacy of rivaroxaban for the prevention of venous thrombembolism after knee arthroscopy

Trial Profile

Efficacy of rivaroxaban for the prevention of venous thrombembolism after knee arthroscopy

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Deep vein thrombosis; Venous thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ERIKA
  • Most Recent Events

    • 14 Apr 2016 Results published in the Thrombosis and Haemostasis
    • 14 Apr 2016 Status changed from recruiting to completed, according to the results published in the Thrombosis and Haemostasis.
    • 03 Jul 2013 Planned end date changed from 1 Jan 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top